Obstetrics & Gynaecology Forum Volume 29 | Issue 2 | 2019

References: 1. Impact Rx – September 2018, Data on file. Results of a survey of 64 South African gynaecologists, commissioned by iNova and undertaken by a third party in February 2017. 2. MetrogelV approved package insert, 2000/10/23. 3. Thrush and Bacterial vaginosis. Looking after your sexual health [online] [cited 22 March 2018]; Available from URL: http://www.sexualhealthsheffield.nhs.uk/wp-content/uploads/2015/03/thrush-bacterial-vaginosis-information-and-advice.pdf. 4. Ries AJ.Treatment ofVaginal Infections: Candidiasis, BacterialVaginosis, and Trichomoniasis. J Am Pharm Assoc. 1997;NS37:563-9. 5. Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR 2015;64(3):1-137. 6. Hanson JM, McGregor JA, Hillier S, et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med. 2000;45(11):889-96. 7. Wain A. MetronidazoleVaginal Gel 0.75% (MetroGeI-Vaginal®) A Brief Review. Infectious Diseases in Obstetrics and Gynecology 1998;6:3-7. 8. Beigi R, Austin M, Meyn L, et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology 2004;191:1124-9. VISIT www.myvaginalgel.co.za TO FIND OUT MORE N O S C R I P T R E Q U I R E D 2 PREFERRED BY SOUTH AFRICAN GYNAECOLOGISTS Metronidazole Gel 0.75 % is a recommended regimen for the treatment of B 5 • Why treat orally when you can treat topically 2 • Comparable efficacy to oral metronidazole, with lower systemic absorption and improved systemic tolerability 6,7 • Comparable efficacy to intravaginal clindamycin, with little to no development of resistance 8 IS THE MOST COMMON VAGINAL INFECTION , AFFECTING 1 out of 3 WOMEN 3,4 B Schedulingstatus: S2 Proprietaryname (anddosage form): MetroGelVVaginalGel. Composition: Metronidazole37.5mg/5g. Preservatives :Methylhydroxybenzoate0.08%,Propylhydroxybenzoate0.02%. Pharmacologicalclassification: A20.2.6Antimicrobial: medicinesagainstprotozoa. Indications: MetroGelV is indicated for the treatmentofbacterialvaginosis . Registration number: 33/20.2.6/0243. Name and business address of applicant: iNova Pharmaceuticals (Pty) Limited. Co. Reg. No. 1952/001640/07, 15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za . For full prescribing information, refer to the package insert as approved by the SAHPRA (South African Health Products Regulatory Authority). Further information is available on request from iNova Pharmaceuticals. IN2900/18. vaginal gel metronidazole 0.75% EMPOWERINGWOMEN SHE DOESN’T HAVE TIME TO LET ACTERIAL AGINOSIS ( ) GET HER DOWN B B